Tradestie Institutional Equity Comparison Engine
XNCR vs VKTX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
XNCR Overall Edge
XNCR Captures Institutional Edge (3โ1 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Xencor, Inc. (XNCR) driven by superior Valuation, Momentum & Technical, Options & Structure while VKTX counters with relative strength in Growth & Margin. Fundamentally, XNCR trades at 68.0x Forward P/E with -72.7% operating margin (+454.9% YoY revenue) versus VKTX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, XNCR sits in BREAKOUT (10th %ile IV; Dealer Gamma Walls on Pro) against VKTX sits in BREAKDOWN (88th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
XNCR
XNCR 68.0x vs VKTX N/M Fwd P/E
Growth & Margin Winner
VKTX
Op Margin -72.7% vs 0.0% ยท YoY +454.9% vs +0.0%
Momentum & Technical Winner
XNCR
1Y +154.5% vs -31.1% ยท 52W Pos 84% vs 16%
Options & Structure Winner
XNCR
BREAKOUT (10th %ile IV) vs BREAKDOWN (88th %ile IV)
XNCR
NASDAQ
Xencor, Inc.
Pharmaceutical Preparations
$35.61
-3.99% 1D
Market Cap
$2.9B
1M Return
+55.84%
1Y Return
+154.54%
Forward P/E
68.0x
Unified AI Score
29.6 / 100
SELL
Tech 50.0
Fund 32.0
Flow 66.0
Mom 40.0
VKTX
NASDAQ
Viking Therapeutics, Inc
Pharmaceutical Preparations
$26.86
-8.08% 1D
Market Cap
$3.8B
1M Return
+6.71%
1Y Return
-31.13%
Forward P/E
N/M
Unified AI Score
46.5 / 100
HOLD
Tech 45.0
Fund 53.0
Flow 71.0
Mom 54.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
XNCR +154.54%
VKTX -31.13%
Spread: +185.67 pp (XNCR Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
XNCR TTM Op. Margin: -72.7%
VKTX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XNCR vs VKTX. Trailing 12-month operating profitability (XNCR -72.7% vs VKTX 0.0%) and valuation multiples (XNCR 68.0x vs VKTX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | XNCR | VKTX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.9B | $3.8B | Larger Scale | VKTX |
| Trailing P/E Ratio Valuation | 68.0x | N/M | Lower Multiple | XNCR |
| Forward P/E Ratio Valuation | 68.0x | N/M | Lower Multiple | XNCR |
| Revenue Growth (YoY) Growth | +454.9% | +0.0% | Higher Growth | XNCR |
| Operating Margin (TTM) Profitability | -72.7% | 0.0% | Higher Margin | VKTX |
| Net Profit Margin Profitability | -58.8% | 0.0% | Higher Margin | VKTX |
| Return on Equity (ROE) Capital Efficiency | -19.9% | -96.4% | Higher ROE | XNCR |
| 52-Week Range Position Momentum | 84% ($10โ$41) | 16% ($24โ$43) | Stronger Trend | XNCR |
| Beta / 30D Volatility Risk Regime | 1.21ฮฒ ยท 87% Vol | 1.52ฮฒ ยท 74% Vol | Lower Realized Risk | VKTX |
| Unified Institutional Score Composite Signal | 29.6 / 100 (SELL) | 46.5 / 100 (HOLD) | Higher Composite | VKTX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full XNCR vs VKTX Buy Guide
XNCR
BREAKOUT
58d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
10th %ile
IV Regime
Compressed (<25th %ile)
VKTX
BREAKDOWN
93d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
88th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither XNCR nor VKTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.